Osiris Provides Update Regarding NASDAQ Listing Matters

Osiris Provides Update Regarding NASDAQ Listing Matters


Osiris Therapeutics, Inc. today provided an update regarding the status of its compliance with the Listing Rules of the NASDAQ Stock Market . As previously disclosed, the Company participated in a hearing before the NASDAQ Hearings Panel on November 10, 2016 in connection with the Company's late filings and the Company's anticipated financial restatement relating to prior periods.



from Biotech News